Whole-exome sequencing identifies a CD38 variant in a Chinese family with hodgkin's lymphoma.
Hodgkin's lymphoma (HL) exhibits genetic susceptibility, but little is known about the pathogenic genes associated with the disease.
APA
Chen X, Xie L, et al. (2026). Whole-exome sequencing identifies a CD38 variant in a Chinese family with hodgkin's lymphoma.. Annals of hematology, 105(1), 10. https://doi.org/10.1007/s00277-026-06807-6
MLA
Chen X, et al.. "Whole-exome sequencing identifies a CD38 variant in a Chinese family with hodgkin's lymphoma.." Annals of hematology, vol. 105, no. 1, 2026, pp. 10.
PMID
41535502
Abstract
Hodgkin's lymphoma (HL) exhibits genetic susceptibility, but little is known about the pathogenic genes associated with the disease. Herein, we present a case of two siblings from a consanguineous Chinese family who were both diagnosed with nodular sclerosis classical HL. The female child and male child were diagnosed at the ages of 22 and 29, respectively, both presenting with involvement of the neck and mediastinal lymph nodes, and poor response or relapse shortly after the first-line treatment. Whole-exome sequencing of the four family members revealed a novel pathogenic missense mutation in the CD38 gene (c.418 C > T, p.Arg140Trp), which was found to be inherited in an autosomal recessive manner. Herein, we identified a putative pathogenic genetic variant that may be associated with HL, which will contribute to improve the understanding of the genetic molecular mechanisms underlying the disease.
MeSH Terms
Adult; Female; Humans; Male; Young Adult; ADP-ribosyl Cyclase 1; China; Exome Sequencing; Hodgkin Disease; Membrane Glycoproteins; Mutation, Missense; Pedigree; East Asian People
같은 제1저자의 인용 많은 논문 (5)
- Rare fusion transcript in a refractory adult T-cell lymphoblastic lymphoma.
- Rabdosin B suppresses proliferation of nonsmall cell lung cancer by regulating the SRC/PI3K/AKT signaling pathway.
- Development of a chemiluminescence immunoassay for proGRP in human serum.
- Genetically encoded biosensors in microbes for Tumor targeting.
- Analysis of discordant results in multi-technique platform-based MRD detection in multiple myeloma and the clinical decision-making dilemma.